IGF 1 LR3 Mactropin: Compound Profile
IGF-1 LR3 Mactropin is a synthetic analogue of insulin-like growth factor-1, engineered with amino acid substitutions and an N-terminal extension to enhance stability and bioactivity. This research-grade peptide represents an advanced tool for investigating IGF-1 receptor signalling pathways in cellular and molecular biology studies. The Long R3 variant incorporates modifications that extend the compound’s half-life compared to native IGF-1, making it particularly valuable for sustained cell culture experiments. Research scientists at Stroid UK Shop utilise this compound to examine growth factor biology, receptor kinetics, and downstream signalling cascades in controlled laboratory environments. The peptide’s enhanced stability profile allows for extended experimental timeframes without frequent media changes, supporting comprehensive dose-response studies and temporal analysis of cellular responses.
Laboratory Applications
Research applications for IGF-1 LR3 span multiple disciplines within cellular and molecular biology. Cell culture studies examine its effects on proliferation, differentiation, and metabolic processes in various cell lines including myoblasts, adipocytes, and hepatocytes. Researchers investigate the compound’s interaction with IGF-1 receptors and insulin receptors, analysing binding affinity, signal transduction pathways, and downstream gene expression changes. The extended half-life characteristics make it suitable for studies examining sustained growth factor exposure effects, particularly in models investigating muscle cell development, adipogenesis, and glucose metabolism. Scientists working with IGF-1 peptides utilise this variant to understand the temporal dynamics of growth factor signalling. Comparative studies often examine differences between native IGF-1 and this modified analogue, providing insights into structure-activity relationships. Research protocols frequently incorporate IGF-1 LR3 in combination with other growth factors and hormones available through SARMs research to investigate synergistic effects on cellular processes.
Product Specifications
| Parameter | Specification |
|---|---|
| Peptide Sequence | Modified 83 amino acid sequence |
| Molecular Weight | Approximately 9.1 kDa |
| Purity | ≥98% (HPLC verified) |
| Formulation | Lyophilised powder |
| Storage Temperature | -20°C (long-term) |
| Reconstitution | Sterile water or appropriate buffer |
| Stability | Enhanced vs native IGF-1 |
| Manufacturer | Mactropin Laboratories |
Quality control procedures include high-performance liquid chromatography for purity verification, mass spectrometry for molecular weight confirmation, and endotoxin testing for cell culture suitability. Storage recommendations ensure peptide integrity throughout extended research programmes. The lyophilised format provides convenience for laboratory protocols while maintaining compound stability. Researchers working with peptide research appreciate the consistent quality and reproducible results achieved with Mactropin’s manufacturing standards.
Research Compliance
This IGF-1 LR3 Mactropin product is manufactured and supplied exclusively for in-vitro laboratory research purposes. It is not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must possess appropriate scientific credentials and institutional oversight to purchase and utilise this compound. All laboratory studies should follow established protocols for peptide handling, storage, and disposal. This product is not intended for diagnostic purposes or clinical applications.
